Anzahl der Einträge: 8.
2018
Werner, Jens Martin,
Damian, Michael,
Farkas, Stefan A.,
Schlitt, Hans J. ,
Geissler, Edward K. und
Hornung, Matthias
(2018)
Murine DX5+NKT Cells Display Their Cytotoxic and Proapoptotic Potentials against Colitis-Inducing CD4+CD62Lhigh T Cells through Fas Ligand.
Journal of Immunology Research 2018, S. 1-8.
Proneth, Andrea,
Schnitzbauer, Andreas A.,
Schenker, Peter,
Wunsch, Andreas,
Rauchfuss, Falk,
Arbogast, Helmut,
Manekeller, Steffen,
Nadalin, Silvio,
Heise, Michael,
Ströhlein, Michael A.,
Banas, Bernhard,
Schemmer, Peter,
Becker, Thomas,
Bechstein, Wolf O. ,
Pascher, Andreas,
Viebahn, Richard ,
Geissler, Edward K.,
Schlitt, Hans J. und
Farkas, Stefan A.
(2018)
Extended Pancreas Donor Program—The EXPAND Study.
Transplantation 102 (8), S. 1330-1337.
Volltext nicht vorhanden.
2016
Renner, Philipp,
Schuhbaum, Jürgen,
Kroemer, Alexander,
Zeman, Florian,
Loss, Martin,
Lang, Sven A.,
Geissler, Edward K.,
Schlitt, Hans J. und
Farkas, Stefan A.
(2016)
Morbidity of hepatic resection for intermediate and advanced hepatocellular carcinoma.
Langenbeck's Archives of Surgery 401 (1), S. 43-53.
Volltext nicht vorhanden.
2015
Brunner, Stefan,
Weber, Florian,
Werner, Jens M.,
Agha, Ayman,
Farkas, Stefan A.,
Schlitt, Hans-Jürgen und
Hornung, Matthias
(2015)
Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification.
BMC Surgery 15 (49), S. 1-10.
2013
2011
Werner, Jens M.,
Busl, Elisabeth,
Farkas, Stefan A.,
Schlitt, Hans J.,
Geissler, Edward K. und
Hornung, Matthias
(2011)
DX5+NKT cells display phenotypical and functional differences between spleen and liver as well as NK1.1-Balb/c and NK1.1+ C57Bl/6 mice.
BMC immunology 12, S. 26.
2010
Schnitzbauer, Andreas A.,
Scherer, Marcus N.,
Rochon, Justine,
Sothmann, Johannes,
Farkas, Stefan A.,
Loss, Martin,
Geissler, Edward K.,
Obed, Aiman und
Schlitt, Hans J.
(2010)
Study Protocol: A Pilot Study to Determine the Safety and Efficacy of Induction-Therapy, De Novo MPA and Delayed mTOR-Inhibition in Liver Transplant Recipients with Impaired Renal Function. PATRON-Study.
BMC Nephrology 11 (24).
2006
Diese Liste wurde erzeugt am Fri Apr 19 11:00:26 2024 CEST.